Bo. Oyajobi et al., TRANSFORMING GROWTH-FACTOR-BETA INCREASES ECTO-NUCLEOSIDE TRIPHOSPHATE PYROPHOSPHATASE ACTIVITY OF HUMAN BONE-DERIVED CELLS, Journal of bone and mineral research, 9(1), 1994, pp. 99-109
Inorganic pyrophosphate (PPi) may be involved in the regulation of min
eralization. The cell surface enzyme, ecto-NTP pyrophosphatase, could
be a major source of extracellular PPi in bone, and agents that influe
nce its activity in osteoblasts may modulate bone mineralization. We s
tudied the effects of serum on the ecto-NTP pyrophosphatase activity o
f cultured human osteoblast-like cells. Enzyme activity was lowered wh
en the concentration of fetal calf serum (FGS) was reduced from 10 to
2.5% (vol/vol) for 48 h, and a further decrease in activity was observ
ed after 96 h. Relative to enzyme activity in cells cultured in serum-
free medium for 96 h, adult human platelet-poor plasma (HPPP; 2.5-10%
vol/vol) induced a small increase, similar concentrations of adult hum
an serum (HS) induced much larger increases, and charcoal-depleted FCS
was ineffective. In an attempt to identify the factor(s) present in s
erum that influence ecto-NTP pyrophosphatase activity, we examined tra
nsforming growth factor-beta (TGF-beta) and platelet-derived growth fa
ctor (PDGF). PDGFs AA, AB, and BB (0.1-10 ng/ml) were ineffective, but
both TGF-beta(1) and TGF-beta(2) increased enzyme activity. The incre
ase was dose dependent between 0.001 and 10 ng/ml, was enhanced in the
presence of 2% vol/vol FCS, and was not potentiated by PDGF or by 1,2
5-(OH)(2)D-3. Furthermore, the increase was independent of cell densit
y and was blocked by inhibitors of protein and RNA synthesis. Ecto-NTP
pyrophosphatase of subject-matched human dermal fibroblasts was unaff
ected by TGF-beta (10 ng/ml), suggesting that modulation of activity b
y the growth factor may be tissue specific. Alkaline phosphatase (ALP)
probably serves to hydrolyze extracellular PPi in bone. In contrast t
o effects on NTP pyrophosphatase activity in osteoblast-like cells, TG
F-beta(1) and TGF-beta(2) (0.001-10 ng/ml) decreased ALP activity dose
dependently after 72 h. By inducing opposing changes in ecto-NTP pyro
phosphatase and ALP activities, TGF-beta may increase extracellular PP
i concentrations in osseous tissues and consequently modulate bone min
eral properties in vivo.